Predictors of postoperative recurrence of pheochromocytoma: a monocentric study

被引:0
作者
Zhuoran Li [1 ]
Dong Lai [2 ]
Yuqi Jia [1 ]
Jin Luo [1 ]
Xin Ma [2 ]
Xu Zhang [2 ]
Lu Tang [2 ]
Xintao Li [3 ]
Baojun Wang [2 ]
机构
[1] Medical School of Nankai University, Tianjin
[2] Department of Urology, Chinese PLA General Hospital/PLA Medical School, Beijing
[3] Department of Urology, Chinese Air Force Medical Center, Beijing
基金
中国国家自然科学基金;
关键词
Epidemiology; Pheochromocytoma; Recurrence; Risk factors;
D O I
10.1186/s12893-025-02824-w
中图分类号
学科分类号
摘要
Objective: To discuss the risk factors affecting the recurrence of pheochromocytoma (PCC) following surgery. Methods: We retrospectively reviewed patients who were hospitalized and underwent surgery for PCC between January 2012 and December 2020 at Chinese People’s Liberation Army (PLA) General Hospital. Inclusion criteria were pathological diagnosis of PCC and availability of follow up. Results: In total, 451 patients met the inclusion criteria. The average age was 45.89 years, and the median tumor diameter was 5.75 cm. The mean recurrence time was 34.24 months. Of the 451 patients receiving surgery, there were 35 recurrent cases (7.85%). The univariate test showed that age, hypertension, history of PCC recurrence, Ki-67 index ≥ 5, bilateral tumor, duration of phenazopyridine administration, DBP at admission, open operation, intraoperative HR minimum, the number of episodes of intraoperative HR over 120 bpm, the number of episodes of intraoperative hemodynamic instability, and intraoperative bleeding were associated with recurrence after surgery. Multivariate COX regression analysis of age (hazard ratio 0.95), hypertension (hazard ratio 7.14), history of PCC recurrence (hazard ratio 69.35), family history of hypertension (hazard ratio 16.30), bilateral tumor (hazard ratio 7.38), tumor size (hazard ratio 1.05), the number of episodes of hemodynamic instability (hazard ratio 114.91) and duration of intraoperative instability (hazard ratio 1.12) were the independent risk factors on recurrence following surgery. Conclusions: Age, hypertension, history of PCC recurrence, family history of hypertension, bilateral tumor, tumor size, the number of episodes and the duration of intraoperative hemodynamic instability were independent risk factors on recurrence following surgery. Clinical trial number: Not applicable. © The Author(s) 2025.
引用
收藏
相关论文
共 38 条
  • [1] Fliedner S.M.J., Brabant G., Lehnert H., Pheochromocytoma and paraganglioma: genotype versus anatomic location as determinants of tumor phenotype, Cell Tissue Res, 372, 2, pp. 347-365, (2018)
  • [2] Lam A.K., Update on adrenal tumours in 2017 world health organization (WHO) of endocrine tumours, Endocr Pathol, 28, 3, pp. 213-227, (2017)
  • [3] Farrugia F.A., Charalampopoulos A., Pheochromocytoma, Endocr Regul, 53, 3, pp. 191-212, (2019)
  • [4] Parasiliti-Caprino M., Lucatello B., Lopez C., Et al., Predictors of recurrence of pheochromocytoma and paraganglioma: a multicenter study in Piedmont, Italy, Hypertens Res, 43, 6, pp. 500-510, (2020)
  • [5] Schovanek J., Martucci V., Wesley R., Et al., The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study, BMC Cancer, 14, (2014)
  • [6] Cui Y., Ma X., Gao Y., Et al., Local-Regional recurrence of pheochromocytoma/paraganglioma: characteristics, risk factors and outcomes, Front Endocrinol (Lausanne), 12, (2021)
  • [7] Moog S., Castinetti F., DoCao C., Et al., Recurrence-Free survival analysis in locally advanced pheochromocytoma: first appraisal, J Clin Endocrinol Metab, 106, 9, pp. 2726-2737, (2021)
  • [8] Dhir M., Li W., Hogg M.E., Et al., Clinical predictors of malignancy in patients with pheochromocytoma and paraganglioma, Ann Surg Oncol, 24, 12, pp. 3624-3630, (2017)
  • [9] Liu Z., Ma J., Jimenez C., Zhang M., Pheochromocytoma, A clinicopathologic and molecular study of 390 cases from a single center, Am J Surg Pathol, 45, 9, pp. 1155-1165, (2021)
  • [10] Press D., Akyuz M., Dural C., Et al., Predictors of recurrence in pheochromocytoma, Surgery, 156, 6, pp. 1523-1528, (2014)